JP2015533174A5 - - Google Patents

Download PDF

Info

Publication number
JP2015533174A5
JP2015533174A5 JP2015536950A JP2015536950A JP2015533174A5 JP 2015533174 A5 JP2015533174 A5 JP 2015533174A5 JP 2015536950 A JP2015536950 A JP 2015536950A JP 2015536950 A JP2015536950 A JP 2015536950A JP 2015533174 A5 JP2015533174 A5 JP 2015533174A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
core
weight
composition according
lubricant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015536950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015533174A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/064596 external-priority patent/WO2014059309A1/en
Publication of JP2015533174A publication Critical patent/JP2015533174A/ja
Publication of JP2015533174A5 publication Critical patent/JP2015533174A5/ja
Pending legal-status Critical Current

Links

JP2015536950A 2012-10-11 2013-10-11 ピロカルピンの医薬製剤 Pending JP2015533174A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261712784P 2012-10-11 2012-10-11
US61/712,784 2012-10-11
PCT/US2013/064596 WO2014059309A1 (en) 2012-10-11 2013-10-11 Pharmaceutical formulations of pilocarpine

Publications (2)

Publication Number Publication Date
JP2015533174A JP2015533174A (ja) 2015-11-19
JP2015533174A5 true JP2015533174A5 (enExample) 2016-12-01

Family

ID=50475520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015536950A Pending JP2015533174A (ja) 2012-10-11 2013-10-11 ピロカルピンの医薬製剤

Country Status (5)

Country Link
US (1) US20140105976A1 (enExample)
JP (1) JP2015533174A (enExample)
KR (1) KR20150068460A (enExample)
CA (1) CA2885979A1 (enExample)
WO (1) WO2014059309A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2479213B (en) 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
EP2706997B1 (en) 2011-05-10 2019-03-27 TheraVida, Inc. Combinations of solifenacin and pilocarpine for the treatment of overactive bladder
KR102600541B1 (ko) 2016-01-20 2023-11-08 테라비다, 인코포레이티드 다한증을 치료하기 위한 방법 및 조성물
EP3749303A4 (en) * 2018-02-05 2022-01-26 Cellixbio Private Limited COMBINATION OF AN ANTIMUSCARINE OR ANTICCHOLINERGIC AGENT AND LIPOIC ACID AND USES THEREOF
US20210100275A1 (en) * 2018-02-19 2021-04-08 Sensient Colors Llc Compositions for coating edible substrates and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60322371D1 (de) * 2002-03-29 2008-09-04 Alza Corp Volumensparende arzneiform zur kontrollierten freisetzung
AR045957A1 (es) * 2003-10-03 2005-11-16 Novartis Ag Composicion farmaceutica y combinacion
WO2006026556A2 (en) * 2004-08-27 2006-03-09 Spherics, Inc. Bioadhesive rate-controlled oral dosage formulations
CA2566311A1 (en) * 2004-05-19 2005-12-08 Glatt Air Techniques, Inc. Micropellet containing pellets and method of preparing such pellets
WO2006031420A2 (en) * 2004-08-27 2006-03-23 Spherics, Inc. Multi-layer tablets and bioadhesive dosage forms
GB2479213B (en) * 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder

Similar Documents

Publication Publication Date Title
JP2011510024A5 (enExample)
JP5911969B2 (ja) 心臓血管障害の治療方法
NZ602075A (en) Abuse-resistant formulations
JP2013522373A5 (enExample)
JP2008501025A5 (enExample)
JP2017525712A5 (enExample)
JP2016528302A5 (enExample)
JP2014167026A5 (enExample)
JP2017088610A (ja) 7−[4−(4−ベンゾ[b]チオフェン−4−イル−ピペラジン−1−イル)ブトキシ]−1H−キノリン−2−オン又はその塩を含む錠剤
JP2015509539A5 (enExample)
JP2016516698A5 (enExample)
HRP20161210T4 (hr) Formulacija obložene tablete i postupak
JP2005538104A5 (enExample)
JP2012144577A5 (enExample)
JP2011503048A5 (enExample)
HRP20240564T1 (hr) Novi farmaceutski sastav
JP2020530832A5 (enExample)
JP2010527347A5 (enExample)
JP2007509891A5 (enExample)
RU2011152105A (ru) Составы таблеток 3-цианохинолина и их применение
JP2007182451A5 (enExample)
JP2016530238A5 (enExample)
HRP20191072T1 (hr) Farmaceutski pripravak s produljenim otpuštanjem trimetazidina
CN115025060A (zh) 含ω-3脂肪酸酯和他汀类的口服给药复合制剂
RU2016106336A (ru) Противотуберкулезная композиция, содержащая рифампицин, изониазид, этамбутол и пиразинамид, и способ ее получения